Sirius Medical
Private Company
Total funding raised: $12M
Overview
Sirius Medical is a private, commercial-stage medical device company focused on oncology surgery. Its core product, the Sirius Pintuition® system, uses a tiny implanted magnetic marker and a handheld detection probe with GPSDetect™ software to navigate surgeons to tumors during breast-conserving lumpectomies. The company has achieved EU MDR certification and US FDA clearance, established key commercial partnerships, and is actively expanding its global presence. Its technology addresses the limitations of traditional wire localization, aiming for better surgical precision, cosmetic results, and workflow efficiency.
Technology Platform
Surgical Marker Navigation platform consisting of an implantable permanent magnetic marker, a handheld multi-sensor detection probe, and GPSDetect™ software providing real-time audio/visual guidance for tumor localization during surgery.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Competes in the advanced tumor localization market against technologies like radioactive seed localization (e.g., Savi Scout) and radar-based systems (e.g., LOCalizer). Must displace the entrenched, lower-cost standard of wire-guided localization. Competitive advantages include no radiation, flexible pre-operative placement, and intuitive multi-sensory guidance.